Benjamin F. Edwards & Company, Inc. Charles River Laboratories International, Inc. Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 745 shares of CRL stock, worth $124,310. This represents 0.0% of its overall portfolio holdings.
Number of Shares
745
Previous 695
7.19%
Holding current value
$124,310
Previous $188,000
18.09%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
694Shares Held
52MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$849 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$624 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$355 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$324 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...